Novel inhibitors of SARS coronaviruses targeting ACE2
- Funded by Australian Government (Australian Research Council)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$538,560.31Funder
Australian Government (Australian Research Council)Research Location
AustraliaLead Research Institution
Burnet InstituteResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
MRFF Antiviral Development for COVID-19 Grant Opportunity research recipient